Magnesium

Pharmacology & Research

Magnesium is an essential mineral and a cofactor for more than 300 enzymes, so true deficiency touches nerve, muscle, cardiovascular and metabolic function broadly. That makes its supplement story two-sided: correcting a deficit has wide effects, but in already-replete people the benefits of extra magnesium are usually modest. The most consistent human data are for blood pressure, blood sugar and migraine prevention — real but small average effects, larger in people who are deficient or already on treatment — plus a dependable osmotic laxative action. Claims for sleep, mood and muscle cramps are popular but rest on thin or largely negative evidence.

0. Evidence by application

Support is an experimental score I’m building — a composite weighted by study type (human > animal > in vitro > review) and study volume. It’s a beta: a fast way to rank strength of evidence at a glance, not a validated metric. Each application links down to its write-up.

Application	Support	Rests on
Constipation	████████░░ 78%	Established osmotic-laxative pharmacology + RCT 11Reference 11Mori S et al. · 2019RCTA randomised double-blind placebo-controlled trial of magnesium oxide in patients with chronic constipation — randomised controlled trialView study →
Blood pressure	██████░░░░ 64%	Consistent meta-analyses; small average effect, bigger if deficient/treated 1Reference 1Argeros Z et al. · 2025Meta-analysisMagnesium supplementation and blood pressure — systematic review and meta-analysis of randomised controlled trialsView study →
Blood sugar (type 2 diabetes)	██████░░░░ 60%	Dose-response meta-analysis; clearest ≥300–500 mg/day + deficiency 2Reference 2Asbaghi O et al. · 2022Meta-analysisEffects of oral magnesium supplementation on glycaemic control in type 2 diabetes — systematic review and dose-response meta-analysisView study →
Migraine prophylaxis	█████░░░░░ 52%	Meta-analysis positive; individual RCTs conflict 3,4,5Reference 3Talandashti MK et al. · 2025Meta-analysisEffects of selected dietary supplements on migraine prophylaxis — systematic review and dose-response meta-analysis of randomised controlled trialsView study →Reference 4Peikert A et al. · 1996RCTProphylaxis of migraine with oral magnesium — a prospective, multicentre, placebo-controlled, double-blind randomised studyView study →Reference 5Pfaffenrath V et al. · 1996RCTMagnesium in the prophylaxis of migraine — a double-blind, placebo-controlled randomised study (null result)View study →
Depression & anxiety	████░░░░░░ 44%	Small RCTs, high heterogeneity, effect likely inflated 6Reference 6Moabedi M et al. · 2023Meta-analysisMagnesium supplementation beneficially affects depression in adults with depressive disorder — systematic review and meta-analysis of randomised clinical trialsView study →
Sleep	███░░░░░░░ 34%	3 low-quality trials; ~17 min faster sleep onset 7Reference 7Mah J · 2021Meta-analysisOral magnesium supplementation for insomnia in older adults — systematic review and meta-analysisView study →

1. Constipation

Magnesium’s most concrete effect is pharmacological, not nutritional: unabsorbed magnesium salts draw water osmotically into the gut and stimulate motility. A double-blind RCT of magnesium oxide (1.5 g/day, 28 days) significantly improved bowel-movement frequency, stool form and quality of life in chronic constipation versus placebo ^{11Reference 11Mori S et al. · 2019RCTA randomised double-blind placebo-controlled trial of magnesium oxide in patients with chronic constipation — randomised controlled trialView study →}. This is the same mechanism behind the diarrhea that limits high supplement doses.

Gap: it’s a laxative effect, dose-dependent and shared by most forms — useful for constipation, but not evidence that “more magnesium” benefits an already-replete person systemically ^{11Reference 11Mori S et al. · 2019RCTA randomised double-blind placebo-controlled trial of magnesium oxide in patients with chronic constipation — randomised controlled trialView study →}.

2. Blood pressure

A 2025 systematic review and meta-analysis of 38 RCTs (n≈2,700, median 365 mg/day) found magnesium lowered systolic blood pressure by about 2.8 mmHg and diastolic by 2.1 mmHg ^{1Reference 1Argeros Z et al. · 2025Meta-analysisMagnesium supplementation and blood pressure — systematic review and meta-analysis of randomised controlled trialsView study →}. The effect is larger in people who are hypomagnesemic or already on antihypertensive drugs, and marginal in healthy normotensives ^{1Reference 1Argeros Z et al. · 2025Meta-analysisMagnesium supplementation and blood pressure — systematic review and meta-analysis of randomised controlled trialsView study →}.

Gap: the average effect is small and clinically modest; magnesium is an adjunct for at-risk or deficient people, not a stand-alone blood-pressure treatment ^{1Reference 1Argeros Z et al. · 2025Meta-analysisMagnesium supplementation and blood pressure — systematic review and meta-analysis of randomised controlled trialsView study →}.

3. Blood sugar (type 2 diabetes)

A dose-response meta-analysis of oral magnesium in type 2 diabetes found meaningful improvements in fasting glucose and HbA1c, strongest at around 500 mg/day and in longer trials, and greater in magnesium-deficient patients ^{2Reference 2Asbaghi O et al. · 2022Meta-analysisEffects of oral magnesium supplementation on glycaemic control in type 2 diabetes — systematic review and dose-response meta-analysisView study →}. Magnesium is a cofactor in insulin signalling and glucose handling, giving the effect a clear mechanism.

Gap: the authors state the evidence is not yet strong enough to guide clinical practice; effects shrink at lower doses and in replete patients ^{2Reference 2Asbaghi O et al. · 2022Meta-analysisEffects of oral magnesium supplementation on glycaemic control in type 2 diabetes — systematic review and dose-response meta-analysisView study →}.

4. Migraine prophylaxis

Migraine is the one neurological use with formal endorsement: professional headache guidelines rate magnesium “probably effective” for prevention, and a 2025 dose-response meta-analysis found supplements reduced attack frequency and monthly migraine days ^{3Reference 3Talandashti MK et al. · 2025Meta-analysisEffects of selected dietary supplements on migraine prophylaxis — systematic review and dose-response meta-analysis of randomised controlled trialsView study →}. A classic RCT of 600 mg/day magnesium dicitrate cut attack frequency by ~42% versus placebo ^{4Reference 4Peikert A et al. · 1996RCTProphylaxis of migraine with oral magnesium — a prospective, multicentre, placebo-controlled, double-blind randomised studyView study →} — but a similarly sized RCT of a different salt found no benefit and stopped early ^{5Reference 5Pfaffenrath V et al. · 1996RCTMagnesium in the prophylaxis of migraine — a double-blind, placebo-controlled randomised study (null result)View study →}.

Gap: RCTs genuinely conflict (salt and dose may matter), certainty is low, and effective doses exceed the supplemental upper limit, so it warrants clinician supervision ^{3,5Reference 3Talandashti MK et al. · 2025Meta-analysisEffects of selected dietary supplements on migraine prophylaxis — systematic review and dose-response meta-analysis of randomised controlled trialsView study →Reference 5Pfaffenrath V et al. · 1996RCTMagnesium in the prophylaxis of migraine — a double-blind, placebo-controlled randomised study (null result)View study →}.

5. Depression & anxiety

A meta-analysis of 7 RCTs in adults with depressive disorder reported a sizeable reduction in depression scores (SMD ≈ −0.92) ^{6Reference 6Moabedi M et al. · 2023Meta-analysisMagnesium supplementation beneficially affects depression in adults with depressive disorder — systematic review and meta-analysis of randomised clinical trialsView study →}. For anxiety the signal is thinner and often premenstrual-specific: magnesium eased fluid-retention PMS symptoms on its own ^{8Reference 8Walker AF et al. · 1998RCTMagnesium supplementation alleviates premenstrual symptoms of fluid retention — randomised controlled crossover trialView study →}, but relieved anxiety-related premenstrual symptoms only when combined with vitamin B6 ^{9Reference 9De Souza MC et al. · 2000RCTA synergistic effect of a daily supplement of magnesium plus vitamin B6 on anxiety-related premenstrual symptoms — randomised, double-blind, crossover studyView study →}.

Gap: the trials are small and heterogeneous, so a −0.9 effect size is very likely inflated relative to what larger studies would show; treat as promising, not proven ^{6Reference 6Moabedi M et al. · 2023Meta-analysisMagnesium supplementation beneficially affects depression in adults with depressive disorder — systematic review and meta-analysis of randomised clinical trialsView study →}.

6. Sleep

A meta-analysis of 3 RCTs in older adults found magnesium shortened time to fall asleep by about 17 minutes versus placebo, but the trials were rated low quality and total sleep time did not significantly improve ^{7Reference 7Mah J · 2021Meta-analysisOral magnesium supplementation for insomnia in older adults — systematic review and meta-analysisView study →}. A newer magnesium bisglycinate trial reported an improvement in insomnia severity that was statistically present but very small.

Gap: the sleep evidence is underwhelming and low-quality; any benefit is modest and clearest in people who are deficient ^{7Reference 7Mah J · 2021Meta-analysisOral magnesium supplementation for insomnia in older adults — systematic review and meta-analysisView study →}.

Mechanisms

Target / pathway	Effect	Relevant to
Cofactor for 300+ enzymes (ATP handling, insulin signalling)	normal nerve, muscle & glucose function	blood sugar, cramps, general
Vascular smooth-muscle relaxation; calcium antagonism	mild vasodilation	blood pressure, migraine
NMDA-receptor / neuronal excitability modulation	dampened over-excitation	migraine, mood, sleep
Osmotic water retention in the gut lumen	softer stool, motility	constipation (and dose-limiting diarrhea)

Pharmacokinetics

Fractional absorption falls as dose rises — from roughly two-thirds at low intakes to around a tenth at high single doses — because uptake has a saturable active component plus a small constant passive one ^{14Reference 14Fine KD et al. · 1991Intestinal absorption of magnesium from food and supplements — human physiology studyView study →}. The practical upshot is to split larger doses and not expect a big single dose to be fully absorbed. Overall, about 30–40% of dietary magnesium is absorbed ^{12Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →}. Salt form matters mainly at the poorly-absorbed end: magnesium oxide sits around 4% fractional absorption, while chloride, lactate and organic salts are substantially higher and roughly comparable to each other ^{15Reference 15Firoz M · 2001Clinical trialBioavailability of US commercial magnesium preparations — comparative human studyView study →}.

Forms of Magnesium

Supplemental magnesium is sold as many different salts and chelates. They differ in three things that actually matter: elemental magnesium (how much magnesium per gram), absorption, and gut tolerance (how likely they are to loosen stools). Each form below has its own page; the comparison:

Form	Elemental Mg	Absorption	Gut / laxative	Best for
Glycinate	~14%	organic chelate; well tolerated	low — gentlest	calm, sleep, sensitive guts
Citrate	~16%	good; better than oxide 15Reference 15Firoz M · 2001Clinical trialBioavailability of US commercial magnesium preparations — comparative human studyView study →	moderate (laxative higher up)	general repletion, mild constipation
L-threonate	~8%	marketed for brain delivery	low	cognition claims (weak evidence)
Oxide	~60%	poor (~4%) 15Reference 15Firoz M · 2001Clinical trialBioavailability of US commercial magnesium preparations — comparative human studyView study →	high — a classic laxative	cheap bulk elemental Mg; constipation
Malate	~15%	organic; presumed good	low–moderate	general use (fatigue claims thin)
Chloride	~12%	good 15Reference 15Firoz M · 2001Clinical trialBioavailability of US commercial magnesium preparations — comparative human studyView study →	moderate	repletion
Sulfate (Epsom)	~10%	oral: osmotic laxative	very high	laxative; bath soaks
Taurate	~9%	presumed organic-tier	low	cardiovascular/calm claims (thin)

The common marketing line that “organic forms absorb better than inorganic” is only half-true: the poorly-absorbed outlier is oxide — inorganic chloride absorbs about as well as organic salts ^{15Reference 15Firoz M · 2001Clinical trialBioavailability of US commercial magnesium preparations — comparative human studyView study →}. Aside from oxide, form differences in absorption are smaller than differences in dose and gut tolerance.

Dosage & Intake

The adult RDA is 310–420 mg/day of elemental magnesium (lower for women, higher for men, rising slightly with age) ^{12,13Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →Reference 13Institute of Medicine et al. · 1997Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride — DRI reportView study →}. Most of that should come from food; typical supplemental doses are 200–400 mg/day of elemental magnesium, best split across the day and taken with food to improve absorption and reduce loose stools ^{12,14Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →Reference 14Fine KD et al. · 1991Intestinal absorption of magnesium from food and supplements — human physiology studyView study →}.

Two things to read carefully on any label: doses are quoted as elemental magnesium here (a “500 mg magnesium glycinate” capsule contains far less elemental magnesium than 500 mg), and the supplemental Tolerable Upper Intake Level is 350 mg/day — notably lower than the RDA, because the UL counts only supplements and medications, not food ^{12,13Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →Reference 13Institute of Medicine et al. · 1997Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride — DRI reportView study →}. These figures describe general intake references and studied ranges, not a personal recommendation.

Safety

Magnesium from food is very safe in healthy people — the kidneys excrete any excess ^{12Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →}. The dose-limiting effect of supplements is gastrointestinal: diarrhea, nausea and cramping, most common with oxide, chloride, carbonate and gluconate, and the basis for the 350 mg/day supplemental upper limit ^{12,13Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →Reference 13Institute of Medicine et al. · 1997Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride — DRI reportView study →}. Serious toxicity (hypermagnesemia — low blood pressure, lethargy, irregular heartbeat) is largely confined to very high doses from magnesium-containing laxatives/antacids and to people with impaired kidney function, who should not supplement without medical advice ^{12Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →}. Magnesium can also reduce absorption of some medicines: separate it by at least 2 hours from oral bisphosphonates and certain antibiotics (tetracyclines, quinolones) ^{12Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →}.

Pregnancy & lactation

Generally recognised as safe within intake guidelines. Magnesium is an essential nutrient with established RDAs in pregnancy and lactation, and food and normal supplemental intakes are considered safe; as with any supplement, high therapeutic doses (e.g. for migraine or as a laxative) should be cleared with a clinician ^{12,13Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →Reference 13Institute of Medicine et al. · 1997Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride — DRI reportView study →}.

Dietary Sources

Magnesium is concentrated in seeds, nuts, leafy greens, legumes and unrefined grains (refining strips the magnesium-rich germ and bran); dark chocolate and mineral-rich water also contribute ^{12Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →}.

Food	Magnesium (per serving)
Pumpkin seeds (1 oz)	~156 mg
Chia seeds (1 oz)	~111 mg
Almonds (1 oz)	~80 mg
Spinach, boiled (½ cup)	~78 mg
Cashews (1 oz)	~74 mg
Black beans, cooked (½ cup)	~60 mg
Peanut butter (2 tbsp)	~49 mg

Roughly 30–40% of dietary magnesium is absorbed ^{12Reference 12National Institutes of Health · 2022ReviewMagnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/View study →}.

References

1. Argeros Z, Xu X, Bhandari B, Harris K, Touyz RM, Schutte AE. (2025). Magnesium supplementation and blood pressure — systematic review and meta-analysis of randomised controlled trials. Hypertension, 82(11), 1844–1856. https://pubmed.ncbi.nlm.nih.gov/41000008/
2. Asbaghi O, Moradi S, Kashkooli S, et al. (2022). Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes — systematic review and dose-response meta-analysis. British Journal of Nutrition, 128(12), 2363–2372. https://pubmed.ncbi.nlm.nih.gov/35045911/
3. Talandashti MK, Shahinfar H, Delgarm P, Jazayeri S. (2025). Effects of selected dietary supplements on migraine prophylaxis — systematic review and dose-response meta-analysis of randomised controlled trials. Neurological Sciences, 46(2), 651–670. https://pubmed.ncbi.nlm.nih.gov/39404918/
4. Peikert A, Wilimzig C, Köhne-Volland R. (1996). Prophylaxis of migraine with oral magnesium — a prospective, multicentre, placebo-controlled, double-blind randomised study. Cephalalgia, 16(4), 257–263. https://pubmed.ncbi.nlm.nih.gov/8792038/
5. Pfaffenrath V, Wessely P, Meyer C, et al. (1996). Magnesium in the prophylaxis of migraine — a double-blind, placebo-controlled randomised study (null result). Cephalalgia, 16(6), 436–440. https://pubmed.ncbi.nlm.nih.gov/8902254/
6. Moabedi M, Aliakbari M, Erfanian S, Milajerdi A. (2023). Magnesium supplementation beneficially affects depression in adults with depressive disorder — systematic review and meta-analysis of randomised clinical trials. Frontiers in Psychiatry, 14, 1333261. https://pubmed.ncbi.nlm.nih.gov/38213402/
7. Mah J, Pitre T. (2021). Oral magnesium supplementation for insomnia in older adults — systematic review and meta-analysis. BMC Complementary Medicine and Therapies, 21(1), 125. https://pubmed.ncbi.nlm.nih.gov/33865376/
8. Walker AF, De Souza MC, Vickers MF, et al. (1998). Magnesium supplementation alleviates premenstrual symptoms of fluid retention — randomised controlled crossover trial. Journal of Women’s Health, 7(9), 1157–1165. https://pubmed.ncbi.nlm.nih.gov/9861593/
9. De Souza MC, Walker AF, Robinson PA, Bolland K. (2000). A synergistic effect of a daily supplement of magnesium plus vitamin B6 on anxiety-related premenstrual symptoms — randomised, double-blind, crossover study. Journal of Women’s Health & Gender-Based Medicine, 9(2), 131–139. https://pubmed.ncbi.nlm.nih.gov/10746516/
10. Garrison SR, Korownyk CS, Kolber MR, et al. (2020). Magnesium for skeletal muscle cramps — Cochrane systematic review and meta-analysis. Cochrane Database of Systematic Reviews, 9, CD009402. https://pubmed.ncbi.nlm.nih.gov/32956536/
11. Mori S, Tomita T, Fujimura K, et al. (2019). A randomised double-blind placebo-controlled trial of magnesium oxide in patients with chronic constipation — randomised controlled trial. Journal of Neurogastroenterology and Motility, 25(4), 563–575. https://pubmed.ncbi.nlm.nih.gov/31587548/
12. National Institutes of Health, Office of Dietary Supplements. (2022). Magnesium — Fact Sheet for Health Professionals — authoritative review. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
13. Institute of Medicine, Food and Nutrition Board. (1997). Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride — DRI report. National Academies Press. https://www.ncbi.nlm.nih.gov/books/NBK109816/
14. Fine KD, Santa Ana CA, Porter JL, Fordtran JS. (1991). Intestinal absorption of magnesium from food and supplements — human physiology study. Journal of Clinical Investigation, 88(2), 396–402. https://pubmed.ncbi.nlm.nih.gov/1864954/
15. Firoz M, Graber M. (2001). Bioavailability of US commercial magnesium preparations — comparative human study. Magnesium Research, 14(4), 257–262. https://pubmed.ncbi.nlm.nih.gov/11794633/